Catch VP22: the hitch-hiker’s ride to gene therapy?
Open Access
- 15 January 1999
- journal article
- perspective
- Published by Springer Nature in Gene Therapy
- Vol. 6 (1) , 4-5
- https://doi.org/10.1038/sj.gt.3300849
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Intercellular trafficking of VP22-GFP fusion proteinsGene Therapy, 1999
- Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22Gene Therapy, 1999
- Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cellsGene Therapy, 1998
- Intercellular delivery of functional p53 by the herpesvirus protein VP22Nature Biotechnology, 1998
- The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctionsGene Therapy, 1997
- Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural ProteinCell, 1997